Skip to main content
OpenTrials

Clinical trial condition

Recurrent or Refractory Glypican 3 (GPC3)

Explore clinical trials studying Recurrent or Refractory Glypican 3 (GPC3). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Recurrent or Refractory Glypican 3 (GPC3) trial results

Recruiting

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

NCT04928677

Conditions
Disease Attributes, Hepatoblastoma, Neoplasms, +8 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States
  • Dana Farber Cancer Institute (Data Collection Only) Boston, Massachusetts, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details

Related conditions